Products Dapsone gel 7.5% (Torrent Pharmaceuticals Ltd) + ACZONE® (dapsone) gel, 7.5% (Allergan, INC.)
Dapsone gel 7.5% (Torrent Pharmaceuticals Ltd) + ACZONE® (dapsone) gel, 7.5% (Allergan, INC.) Phase 3 Completed 📈 Rising Jul 11, 2019 → Feb 22, 2020
About Dapsone gel 7.5% (Torrent Pharmaceuticals Ltd) + ACZONE® (dapsone) gel, 7.5% (Allergan, INC.) Dapsone gel 7.5% (Torrent Pharmaceuticals Ltd) + ACZONE® (dapsone) gel, 7.5% (Allergan, INC.) is a phase 3 stage product being developed by Torrent Pharmaceuticals for Acne Vulgaris. The current trial status is completed. This product is registered under clinical trial identifier NCT04015375. Target conditions include Acne Vulgaris.
Clinical Trials (1) NCT ID Phase Status Start Completion Indication NCT04015375 Phase 3 Completed Jul 11, 2019 Feb 22, 2020 Acne Vulgaris
Product Company Stage Hype Score Olumacostat Glasaretil Gel, 5.0% Eli Lilly Phase 3 HT-001 2% Topical Gel + HT-001 1% Topical Gel + HT-001 0.5% Topical Gel + HT-001 Placebo Hoth Therapeutics Phase 2 Trifarotene Cream 0.005% + AKLIEF® Cream (Trifarotene 0.005%) US REFERENCE LISTED DRUG + AKLIEF® Cream (Trifarotene 50 mcg/g) CANADIAN REFERENCE PRODUCT + Placebo Sun Pharmaceutical Phase 1 Tretinoin Gel Microsphere, 0.1% + RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.1% + Placebo Control Sun Pharmaceutical Phase 1 Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/2.5% + Acanya® Gel, 1.2%/2.5% + Vehicle of test product Sun Pharmaceutical Phase 1 Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel + Duac® Topical Gel + Placebo Topical Gel Sun Pharmaceutical Phase 1 Adapalene Gel 0.1% + Placebo Control + Differin® Gel (Adapalene 0.1%, Galderma) Sun Pharmaceutical Phase 1 Trifarotene Cream 0.005% + Placebo + AKLIEF® Cream (Trifarotene 0.005%, Galderma Laboratories) Sun Pharmaceutical Phase 1 Adapalene/BP gel, 0.3%/2.5% + EPIDUO® FORTE + Placebo Sun Pharmaceutical Phase 1 ADPS topical product + Placebo Control Sun Pharmaceutical Phase 2 Isotretinoin Sun Pharmaceutical Approved Winlevi (Clascoterone) cream 1% Sun Pharmaceutical Approved Adapalene Gel 0.3% + Differin® + Placebo Sun Pharmaceutical Phase 1 CLPG Topical Gel 1% + Clindamycin + Placebo Sun Pharmaceutical Phase 1 Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% + Epiduo® Gel + Placebo Sun Pharmaceutical Phase 1 Test. + Aczone Gel 5% + Placebo Sun Pharmaceutical Phase 1 Clindamycin and Benzoyl Peroxide Gel 1%5% + BenzaClin® Topical Gel + Placebo Sun Pharmaceutical Phase 1 Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% + Onexton™ Gel + Placebo Sun Pharmaceutical Phase 1 Clindamycin Phosphate + Clindamycin Phosphate RLD + Placebos Sun Pharmaceutical Phase 1 Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% + CABTREO Topical Gel + Placebo Control Sun Pharmaceutical Phase 1
Other Products from Torrent Pharmaceuticals